Cellular localization of EYFP-hCAR in CAR-null mice
CAR–/– mice were tail vein-injected with 10 μ g of EYFP-hCAR and treated 2 and 5 h later by intraperitoneal injection of vehicle (DMSO, CTL), 50 mg/kg RIF, 100 mg/kg PB, 10 mg/kg CITCO, 20 mg/kg CMZ, 25 mg/kg EFV, or 50 mg/kg NVP at volumes of 0.1 ml per 20 g body weight. EYFP-hCAR expression was detected in mouse liver sections by confocal laser scanning microscope. For each treatment, over 150 hCAR-expressing cells from two mice livers (M1 and M2) were counted and classified as having cytosolic (C), nuclear (N), or mixed (C + N) hCAR localization. Numbers in parentheses represent the percentages of cells exhibiting the specified localization relative to the total number of counted cells. M1 = mouse 1, M2 = mouse 2.
Compounds | C | N | Mixed | Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
M1 | M2 | M1 | M2 | M1 | M2 | M1 | M2 | |||||
CTL | 142 (88%) | 152 (77%) | 15 (9%) | 35 (18%) | 5 (3%) | 10 (5%) | 162 (100%) | 197 (100%) | ||||
RIF (50 mg/kg) | 155 (91%) | 148 (82%) | 10 (6%) | 30 (16%) | 5 (3%) | 3 (2%) | 170 (100%) | 181 (100%) | ||||
PB (100 mg/kg) | 59 (33%) | 62 (27%) | 113 (64%) | 154 (67%) | 6 (3%) | 13 (6%) | 178 (100%) | 229 (100%) | ||||
CITCO (10 mg/kg) | 67 (37%) | 48 (30%) | 84 (46%) | 61 (40%) | 32 (17%) | 48 (30%) | 183 (100%) | 157 (100%) | ||||
CMZ (20 mg/kg) | 21 (13%) | 26 (14%) | 118 (75%) | 147 (81%) | 18 (12%) | 9 (5%) | 157 (100%) | 182 (100%) | ||||
EFV (25 mg/kg) | 29 (19%) | 41 (19%) | 120 (78%) | 163 (76%) | 5 (3%) | 11 (5%) | 154 (100%) | 215 (100%) | ||||
NVP (50 mg/kg) | 46 (21%) | 40 (21%) | 129 (58%) | 130 (67%) | 47 (21%) | 23 (12%) | 222 (100%) | 193 (100%) |